FindTrial
Sign In

Ferroptosis in children with congenital heart disease

Ferroptosis in children with congenital heart disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066390
Enrollment
Unknown
Registered
2022-12-04
Start date
2022-12-04
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

cyanotic congenital heart disease:N/A
non-cyanotic congenital heart disease group:N/A

Sponsors

Department of Surgical Anaesthesia, Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1) Children with cyanotic and non-cyanotic congenital heart disease undergoing surgical treatment in our hospital; 2) Children of American Society of Anesthesiologists physical status I-V, aged 0-18 years old were included

Exclusion criteria

Exclusion criteria: 1) Parents and children refused to participate in the study 2) The presence of infectious diseases

Design outcomes

Primary

MeasureTime frame
Ferroptosis related indicators;—

Countries

China

Contacts

Public ContactYang Fei

Department of Surgical Anaesthesia, Children's Hospital of Chongqing Medical University

270859993@qq.com13648314370

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026